Cannabis for Migraines and Headaches

Migraines impact more than 39 million men, women, and children in the United States; and are especially common in women. Symptoms include dull and throbbing head pain, piercing cluster pain, neck pain and tension, nausea, and hypersensitivity to light, sound and smells. When left untreated, headaches and migraine may lead to depression and anxiety. 


The causes of migraines are not definitive, but genetics and environment may play a role. Most people with migraine will have a spontaneous attack with no identifiable cause, however common triggers may include stress, diet, alcohol, sleep patterns, changes in weather, hormonal changes, concussions, and traumatic brain injuries.


Current treatments for Migraine and Headache


There are two primary types of treatments for migraine: acute and preventative. Acute treatments include over the counter pain relievers, prescription medications, or devices to stop the pain. Preventative treatments are designed to reduce frequency, severity, and duration of attacks before they occur. 


Research shows that behavioral treatment, such as stress management and biofeedback can help reduce attack frequency and severity. 


Although the pathophysiology of migraine is still fairly elusive in the medical community, there is still an understanding of the main mechanisms underlying migraine attacks, such as neurogenic inflammation. Inflammatory chemicals irritate and dilate blood vessels, which leads to a release of more sensory neurons and increase of pain impulses. 


The Role of the Endocannabinoid System


The endocannabinoid system (ECS) is our physiological system composed of endocannabinoids, their metabolic enzymes, and their receptors. Endocannabinoids within our central nervous system are involved in the modulation of specific brain functions. Through activation of CB1 receptors, endocannabinoids are able to control movement, memory, wake/sleep cycles, thermogenesis, appetite and pain. 


Research published in 2014 suggests that CB2 receptors, especially those located outside the central nervous system, may also play a role in the perception of pain. When studied in animal models, exogenous cannabinoids induced antinociception (the action or process of blocking the detection of a painful or injurious stimulus by sensory neurons). It has been clearly demonstrated that CB1 receptors are involved in modulating pain signals, but this showed that CB2 receptors also contributed to the analgesic effect. 


Endocannabinoid deficiency in head pain studies


Endocannabinoid deficiency has been hypothesized to be a reason why individuals suffer from migraines, with recent clinical studies supporting this idea. However, scientific evidence for the potential efficacy of cannabinoids in migraine is limited. 


Clinical endocannabinoid deficiency was first presented in 2001 by Dr. Ethan Russo and has been further explored since then. Because endocannabinoids are involved in different physiological and pathological processes such as regulating food intake, immunomodulation, inflammation, pain, cancer, addictive behavior, seizure disorders and more; it would seem that if  levels of endocannabinoids (or endocannabinoid function) were decreased in the body, then we would witness a disturbance in digestion, pain threshold, mood, sleep, and more. The greatest evidence for clinical endocannabinoid deficiency is present with PTSD, IBS, fibromyalgia, and migraines as they have common pathophysiological trends, one being that they all display elevated incidences of anxiety and depression. 


Another piece of evidence seen is that, for the most part, these conditions are treatment-resistant. There may be pharmaceutical drugs available to alleviate certain associated symptoms, resulting in one taking several different medications to target the various symptoms, but not one conclusive treatment. 


A study published in 2007 reported reduced levels of the endocannabinoid anandamide (AEA) in the cerebrospinal fluid of patients with chronic migraine. This showed the possibility that reduced levels of AEA (or an endocannabinoid deficiency) may be associated with increased activation of the TVS (trigeminovascular system), a common occurrence before and during migraine attacks. Theoretically, the reduction of AEA levels, and hence the reduced inhibitory effect of ECS, may contribute to facilitating and/or maintaining central sensitization in chronic head pain. 


An important role for AEA in head pain is also observed in that AEA possesses a vasodilator activity and it has been identified also in endothelial cells, confirming its potential role in the modulation of the vascular system. AEA is actually classified as a true “endovanilloid” as it activates the transient receptor potential vanilloid receptor (TRPV1), an ion channel receptor primarily located on sensory nerves and activated by specific stimuli capable of initiating and amplifying pain and inflammation.


Early Cannabinoid Therapy for Migraines and Headaches


The use of cannabis in the symptomatic and prophylactic treatment dates back in research to the early 19th century. Dr. S. Mackenzie advocated the use of cannabis twice daily in 1887 for chronic daily headache. Dr. J.W. Farlow recommended cannabis suppositories in 1889 for nervous headaches. In 1915, Sir William Osler, the acknowledged father of modern medicine, proposed the treatment of migraine with Cannabis indica. The following year, Dr. Dixon, Professor of Pharmacology at the Kings’ College and the University of Cambridge, reported the therapeutic effects of smoked cannabis for headache treatment. Subsequently, the medicinal use of Cannabis indica for both acute and preventative headache treatment was advocated by many more prominent physicians through the 19th and early decades of the 20th centuries. 


In the late 1990s Dr. Ethan Russo had received FDA support in conducting a study looking at the effects of smoked cannabis in the treatment of migraines. However, his study was halted by the National Institute on Drug Abuse (NIDA). He stated the following


“My FDA-approved study on cannabis’ ability to reduce

migraine was stone-walled because NIDA holds a monopoly on

the legal supply of cannabis for research, and they refused to

provide it for my study. As a doctor and a citizen, knowing that

researchers in other countries are researching and confirming

new medical uses for cannabis all the time, such as its ability to

protect the brain after head trauma or stroke, I am dismayed by

policies that prevent us from fully utilizing the healing potential

of this plant and preventing people from using the best medicine

for their condition.”


Medicinal Cannabis and Pain


One of the most documented uses of medicinal cannabis is in the treatment of pain, particularly chronic pain, and suppression of hyperalgesia. Most published studies involve endocannabinoids, delta-9 THC, or synthetic cannabinoids. The cannabinoid-opioid interactions and “opioid-sparing effect” of cannabinoids has attracted interest in medicinal cannabis for a possible alternative to narcotics with less potential for dependence, addiction, and abuse. 


Recent Studies


Both delta-9 THC and CBD have analgesic properties, although they act through different mechanisms, and the potential euphoric side effects of delta-9 THC may be a limiting factor in its use. However, given the pharmacology and reported therapeutic benefits of cannabis in pain medicine, it is logical that this benefit may extend to the arena of headache medicine, including migraines.


A case study reported a woman with medically refractory pseudotumor cerebri would smoke a cannabis cigarette about once per week when her headache disorder became severe. She would have complete resolution of her headache within 5 minutes and it would not recur that day. 


Other studies suggest that cannabinoids may reduce intracranial pressure in traumatic brain injuries (TBI’s) as well as intraocular eye pressure in glaucoma. 


A case study involving one male  reported that smoking cannabis at the onset of cluster headache attack would consistently give complete headache relief. He eventually replaced smoked cannabis with ingestibles, finding the onset time was a few minutes delayed but provided the same relief. Oral administration is associated with slower onset of action and longer duration of action and effects. 


A prospective clinical trial published in 2020 focused on 68 patients who smoked or vaped medical cannabis. The study focused on the associations between phytocannabinoid treatment and migraine frequency reporting better migraine symptom reduction, less negative headache impact, better sleep quality, and decreased medication consumption. Studies have also shown improvements in nausea and vomiting associated with migraines; but also shown to have unpredictable effects due to psychotropic nature. 


A 2021 published study looked at a survey provided to 50 medical cannabis users. It showed that hybrid strains of cannabis of high THC/THCA, low CBD/CBDA strains and those with predominant terpenes b-caryophyllene, and myrcene, were most preferred in headache and migraine groups. It also showed that THC:CBD ratios had a 40% improvement and was potentially best used for acute attacks. 


Research Limitations


While studies have shown improvements in pain as well as nausea and vomiting associated with migraines, limitations exist that prevent a quality analysis. This is why participation in research for the benefit of cannabinoid therapy in specific ailments, such as headaches and migraines, is critical to move science and access forward. If you or someone you know would be interested in joining Realm of Caring’s Observational Research Registry in collaboration with Johns Hopkins University School of Medicine, join today


With all of the information and misinformation available, it is easy to become overwhelmed when beginning cannabinoid therapy. Our trained care specialists are here to help with free support. Set up an appointment, email, or chat  with us today for help in getting started, calculating a dose, or finding a quality product. We are always happy to help answer your questions. 


Blog Education Featured Uncategorized

Cannabinoids and Cardiovascular Health

February is American Heart month, dedicated to bringing awareness and attention to our cardiovascular health. Accumulating evidence suggests that cannabinoids such as CBD may be beneficial to our cardiovascular system. However, research is complex and there is overlap when considering cannabinoids and cardiovascular health, as there are multiple effects that can come from various cannabinoids. 


The endocannabinoid system (ECS) is distributed throughout our cardiovascular system and endocannabinoids have shown to play a role in response to cardiovascular disorders through several studies. Two key endocannabinoids that have been identified in our ECS are Anandamide (AEA) and ​​2-arachidonoylglycerol (2-AG). They have been associated with mediating hypotension, reducing blood pressure, vasorelaxation, and decreasing cardiac work. In addition, endocannabinoids have been connected to decreasing the risk of developing cardiac arrhythmia. Through these studies we can recognize the role of endocannabinoids as largely protective of our cardiovascular system and bodies in general. 


Understanding the roles of endocannabinoids in our cardiovascular health, has led researchers to look into exogenous cannabinoids and potential health benefits as well as potential health risks. Targeting the ECS offers fresh insights to how cannabinoid therapy may benefit specific conditions. 


Cannabidiol (CBD) has been researched for the many ways it may benefit our heart health, some of the most notable therapeutic actions of the molecule are the anti-inflammatory and antioxidant properties. Some cardiovascular conditions and diseases that are associated with inflammation and oxidative stress are diabetes, cardiomyopathy, stroke, arrhythmia, atherosclerosis, and hypertension. The therapeutic potentials of CBD are why it is being considered in research for the prevention and treatment of these conditions and diseases. In addition, CBD has particularly gained momentum because it does not appear to have effects on resting blood pressure or heart rate, rather it has shown in vivo to reduce the cardiovascular response to various stress types. 


While inflammation and oxidative stress are known to have direct effects on our cardiovascular system, studies have shown a correlation between long-term stress and the development of cardiovascular disease as well. Factors including social isolation, socioeconomic status, depression, stressful family/work life, and anxiety are all associated with a potential increased risk in developing and progressing cardiovascular diseases. There is evidence from animal studies that CBD modulates the cardiovascular response to stress. While data found in humans is very limited, at least one study has shown that acute administration of CBD reduced the blood pressure increase to stress in humans, associated with increased heart rate. 


While research is promising when considering CBD and cardiovascular health, we are limited in terms of clinical data to speak to the full therapeutic potential of phytocannabinoids like CBD when it comes to heart conditions or preventing heart conditions. It is also important to note that various cannabinoids of the cannabis plant may have multiple effects on the cardiovascular system. Just as endocannabinoids may act to increase or decrease blood pressure and heart rate, different phytocannabinoids can replicate those same actions. For example, while THC may stimulate systolic blood pressure, CBD may reduce blood pressure. Risks and benefits do need to be further explored and, at this time, almost all studied risks of cannabis are based on users of inhaled combustible smoke.




Join our research!


Realm of Caring and Johns Hopkins University School of Medicine have developed the Observational Research Registry (ORR) to better understand medicinal cannabis use and its impact on key health outcomes including healthcare utilization, chronic pain, anxiety and depression, caregiver burden, epilepsy, and posttraumatic stress disorder (PTSD). Our registered clients provide critical information that leads to important insights into the therapeutic capabilities of medicinal cannabis. The ORR helps us develop client educational resources and may ultimately serve to legitimize the medicinal use of cannabis.






The Realm of Caring Foundation specifically invokes the first amendment rights of freedom of speech and of the press without prejudice. These statements have not been evaluated by the food and drug administration. The products discussed are not intended to diagnose, cure, prevent or treat any disease. Realm of Caring always recommends when and wherever possible that licensed local healthcare professionals be consulted.


The Realm of Caring Foundation is an independent nonprofit with its own governing board. We do not produce or sell cannabinoid products, nor do we receive funds from the sale of other company’s products.


Blog Education Uncategorized

Arthritis and Cannabinoid Therapy

Arthritis is one of the most widespread health conditions in the United States, affecting over 54 million men and women and 300,000 children. Arthritis appears in many forms, with the most common being osteoarthritis (OA), followed by rheumatoid arthritis (RA) and psoriatic arthritis. 


As of today, there is no cure for arthritis (as well as rheumatic conditions), rather recommendations for combination therapies such as increasing physical activity, weight loss, OTC pain relievers, crutches or canes, surgery, and cannabinoid therapy due to recent research. 


What is the Endocannabinoid System?  


Our Endocannabinoid System (ECS) is the largest neurotransmitter system in the body, composed of endocannabinoids, cannabinoid receptors, and metabolizing enzymes. Endocannabinoids are arguably one of the most widespread and versatile signaling molecules known to man. Two key endocannabinoids that have been identified are anandamide (AEA) and 2-arachidonoyl glycerol (2-AG). The endocannabinoids activate different receptors throughout the body and brain called CB1 and CB2 receptors. CB1 receptors are found in high levels in the brain and central nervous system; whereas CB2 receptors are found in numerous immune cells and the peripheral nervous system. Modulation and activation of the cannabinoid receptors by endocannabinoids can have various effects within the body. 


How does ECS play a role in arthritis and rheumatoid conditions? 


In a study with 32 osteoarthritis patients and 13 rheumatoid arthritis patients, it was found that cannabinoid CB1 and CB2 receptor protein and RNA, as well as the endocannabinoids AEA and 2-AG are present in the synovia of patients with end-stage OA and RA. This study helps to predict that the cannabinoid receptor system present in the connective tissue that lines the inside of a joint (synovium) may be an important therapeutic target for the treatment of pain and inflammation associated with both OA and RA. As was seen in this study, the endocannabinoids were present in the OA and RA patients where in healthy volunteers, those endocannabinoids were not present. 


In additional studies, the presence of cannabinoid receptors on cells of the immune system and anecdotal and historical evidence suggests that cannabis use has potent immunomodulatory effects. This has led to research directed at understanding the function and role of these receptors within the context of immunomodulating effects of cannabis in humans, animals and in vitro studies of immune cells, such as t-cells that have also provided important evidence. 


These findings have led researchers to discover the role endocannabinoids and phytocannabinoids may have on inflammation and pain within the body, as well as our immune cells


Researched pain and inflammation relieving benefits of cannabinoids


Cannabinoids are commonly investigated as pain-relieving agents, but in recent years more evidence has accumulated on their potential immunomodulatory effect, supported by results in animal models of certain rheumatic diseases. While results that demonstrate the same effect in humans are lacking, cannabinoids and cannabis remain potential options to alleviate the pain associated with rheumatic diseases, as they were shown as safe and causing little to no adverse effects. 


It has also been suggested that cannabinoids have an inflammatory-modulating benefit that could offer therapeutic effects, as cannabinoids were shown to have overall anti-inflammatory effects on immune cells. These results were reinforced by studies in animal models of RA and systemic sclerosis. 


Animal models also suggest a possible therapeutic quality for cannabinoids in RA, with three studies using a rodent model with collagen-induced arthritis showing a beneficial effect of the cannabinoid CBD and synthetic cannabinoids JWH-133 and HU-308. These substances were found to be associated with clinical improvement. CBD was associated with a decrease in cytokine release and production as well as a decrease in lymphocyte proliferation. 


A study with 31 patients with RA suffering from chronic pain were given Sativex (a THC-CBD mouth spray legally prescribed in UK and mainland Europe) and 27 were given a placebo, the controlled trial showed a significant analgesic effect and disease activity suppression. Pain parameters and sleep both improved. In addition, the study found no serious adverse effects in the active treatment group. 


CBD Benefits


We know through research that CBD has a wide spectrum of biological activity, including anti-inflammatory activity. This is why its activity in the prevention and treatment of diseases whose development is associated with inflammation has been tested. Based on current research results, the potential to utilize CBD for the treatment of diabetes, arthritis, as well as cardiovascular disease, cancer, anxiety, psychosis, epilepsy, neurodegenerative diseases, and skin disease is being considered. Clinical studies have confirmed that CBD reduces the levels of pro-inflammatory cytokines, inhibits t-cell proliferation, induces t cell apoptosis and reduces migration and adhesion of immune cells. 


In addition, CBD creates a physiological response with several inflammatory mediator receptors within us. These are known as the PPARy, GPR, and Adenosine A2A Receptors. 


THC Benefits


The anti-inflammatory contributions of THC are also extensively studied, showing PGE-2 synthesis, decreased platelet aggregation, and stimulation of lipoxygenase, all actions related to reducing inflammation. THC has 20 times the anti-inflammatory potency of aspirin and twice that of hydrocortisone. 


Benefits of minor cannabinoids and terpenes 


Other minor cannabinoids in the cannabis plant may also contribute to anti-inflammatory activity. cannabichromene (CBC) was studied with mice, showing that it helped to increase intestinal motility by lessening intestinal inflammation. 


Animal studies have also shown Cannabigerol (CBG) to reduce the effects of inflammatory-related conditions such as inflammatory bowel disease. CBG has also been shown to have potent pain relieving abilities. 


The terpenes in cannabis additionally show analgesic and anti-inflammatory attributes. Myrcene is analgesic and blocks inflammation. The sesquiterpene, B-caryophyllene, also shows promising anti-inflammatory and analgesic properties. 


If you are seeking data-driven answers to your questions about this cannabinoid therapy and arthritis, Realm of Caring (RoC) can help. RoC has 8 years of collected data and research based on individuals utilizing plant-based therapies. They can guide you through product selection, dosing and administration, how to talk with your doctor, and the results individuals are realizing.


The research that has been completed suggests the benefit of cannabinoid therapy for arthritis and rheumatic conditions. Clinical trials and anecdotal evidence helps to point towards starting amounts and methods of administration, particularly for CBD and THC. However, to fully understand the utility of minor cannabinoids mentioned, human data is still necessary.


The RoC Care Team is here to assist. They care a lot about helping you to find success. Reach them by calling (719) 347-5400, emailing, or by scheduling an appointment.






The Realm of Caring Foundation specifically invokes the first amendment rights of freedom of speech and of the press without prejudice. These statements have not been evaluated by the food and drug administration. the products discussed are not intended to diagnose, cure, prevent or treat any disease. Realm of Caring always recommends when and wherever possible that licensed local healthcare professionals be consulted.


The Realm of Caring Foundation is an independent nonprofit with its own governing board. We do not produce or sell cannabinoid products, nor do we receive funds from the sale of other company’s products.

Blog Education Featured Uncategorized

How Cannabis Concentrates Are Made

At the turn of the century, cannabis enthusiasts began noticing a steep shift in the market. Regular users started smoking less and dabbing more- heating oily extracts to inhale high concentrations of cannabis. These extracts varied from shatter to wax to batter to dabs and honey. Not only were they more potent, but they were also a cleaner and a more convenient way to consume cannabis. This heralded the beginning of a new era.


At the start, cannabis extracts were made using highly flammable hydrocarbons right in their backyards and garages. This was a precarious affair with consequences of explosive proportions, quite literally.


In recent times, the technology of extracting cannabis has grown in leaps and bounds, and we will take you through each of them in great detail.



What Are The Popular Methods of Cannabis Extraction?


When it comes to cannabis extraction, two main methods exist.


Solvent-based extraction: In this method, solvents are added to the plant material to dissolve the resin, which is the concentrated part of the cannabis plant containing the cannabinoids and terpenes. The solvent is then removed, leaving behind extracts such as shatter, vape oil, or wax.


This method yields what is known as a cannabis extract.


Mechanical or solventless extraction: Mechanical or solventless extraction methods do not use solvents. Instead, the resin is pressed, beaten, or rubbed out of the plant, resulting in kief, rosin, or hash.


This method yields what is known as a cannabis concentrate.  



Solvents Used to Make Cannabis Extracts


As discussed earlier, the solvent-based extraction method has been used for quite a long while now.


Let us look in detail at how these solvents work.


Hydrocarbons (Butane, Propane, Hexane, etc.)


Hydrocarbons are used to make butane hash oils (BHO) which includes budder, sauce, wax, shatter, and crumble among others.


Because hydrocarbons are highly flammable, a closed loop system of extraction should be used.


The process of extracting cannabis can be either open-looped or closed-looped. Open-loop systems have exposure to the external environment. When flammable compounds are present, open loop systems can easily cause a fire accident.


Closed-loop systems, on the other hand, are safer but more expensive to implement. Securing the equipment could cost upwards of $30,000 for an average-sized model.


It is also a requirement for manufactures using hydrocarbons to blast-proof the premises. The cost of blast proofing a room could be around $100,000.


CO2 (Supercritical CO2 Extraction)


Supercritical CO2 extraction uses CO2 to separate the different compounds from the cannabis plant material.


The carbon dioxide is subjected to supercritical conditions that causes it to fluctuate between a gas, liquid, and solid-state. It is then passed through the cannabis plant material in a closed loop system to extract the compounds and then the CO2 is evaporated. Because CO2 is a green gas, the extract produced through this method is relatively safe.




Ethanol is a popular solvent used to make super-concentrated Rick Simpson Oil.  It follows the same principle used in creating BHO. With ethanol, the solvent is dripped over the flowers and buds of the cannabis plant, which dissolves these compounds. The next step is to eliminate the solvent and remain with the cannabis extract.


However, ethanol has a higher polarity than butane. This means that it extracts impurities such as chlorophyll, which may affect the quality of the final extract.



Non-Solvent-Based Methods for Making Cannabis Concentrates


Solventless extraction is often used when creating concentrates for medicinal use. This is because the concentrates produced through this method are relatively safer.


Shaking, Sifting, and Dry Sifting-Used to Make Kief


Kief, a type of cannabis concentrate, can be made using different mechanical techniques. 


One technique that has stood the test of time and is exceptionally safe is the use of a mesh. The cannabis plant material is passed through a mesh and the kief collects at the bottom. The kief is then graded based on the level of purity.


Ice Water Extraction


Bubble hash is a popular cannabis extract that is made using kief that has been Ice Water Extracted. It is the brainchild of Neville Schoenmakers, founder of the first Cannabis Seed Bank.


In this method, the cannabis is placed in a simple jar or bubbleator with water and ice and agitated. The resin is separated by the mechanical force and it is collected. Because it uses water, this method is considered to be one of the safest and cleanest ways of making a pure, high-quality hash that has no impurities. It is also a pretty wholesome method of extraction that leaves you with most of the cannabinoids intact.


Heat and Pressure (Rosin Press)


Rosin is a viscous sap whose appearance can range from clear to very dark, and it can be used in its extracted form or as a base for cannabis edibles. Both a rosin press and a rosin bag use pressure and heat to force the trichomes out of the cannabis leaves and buds.



Types of Cannabis Extracts & Concentrates




A runny consistency characterizes wax or budder. These oils are opaque and gooey rather than being hard. It is also easy to roll them onto “a pin and dab,” but they tend to stick to the sides of the packaging container.


Pie Crust/Honeycomb


This is a form of wax/budder which is generally crumbly and brittle. It is, however, softer than shatter. Pie Crust is easier to get out of a jar but is very prone to crumbling.




Shatter is an impressively pure cannabis concentrate that is very brittle and translucent, much like glass candy.  It is mainly extracted using hydrocarbon solvents such as butane and or propane, making it a particularly potent substance.


Caviar/Jelly Hash


Caviar, also known as moonrocks, are a recent fad in the cannabis scene. Making them involves coating cannabis buds with very high-quality resin, which are then rolled in kief.


Caviar doesn’t always have to be rolled in kief, a resin coat may just suffice.






Cannabis extraction is just in its formative stages. With time, we expect to witness the creation of more efficient and purer methods geared towards the production of medicinal cannabis extracts. We hope that through this article, we have helped you understand how cannabis concentrates are made. Feel free to let us know if we left out anything.




About Realm of Caring

Realm of Caring Foundation (RoC), is a 501(c)3 nonprofit organization that was established by parents in 2013 to support families who were out of medical options. By creating educational resources, conducting research, and assisting families with data-rich answers to their questions, RoC continues to be a leader in the cannabinoid (cannabis/hemp) field. RoC’s no-cost Care Team has served more than 65,000 clients worldwide and supports a network of over 2,000 medical professionals. To learn more about participating or to donate to this cause, visit or call 1-888-210-3772.

Blog Education Featured Uncategorized

Cannabidiol (CBD) Product Use and Health Among People with Epilepsy

Blog Education Uncategorized

Surprising Facts You Likely Didn’t Know About Cannabis

Blog Education Featured Uncategorized

April 7th remembered as Charlotte Figi Day in Colorado House and Senate

Blog Education Featured Uncategorized

Eight Years in the Making: Realm of Caring’s Impact Over Time

Blog Featured Uncategorized

Rock the RoC

Rock the RoC is a virtual, memorial and benefit concert to pay tribute to Charlotte Figi. Here is what you should know about the April 7th event, the impactful story behind it and how YOU can get involved. 


Rock the RoC: 04/07 at 6pm MT – Livestreaming at 


Get your free tickets NOW to the largest event Realm of Caring (RoC) has ever hosted; an event that we know you will love: Rock the RoC. We have curated the perfect playlist, to come together to heal, inspire, and groove. We are excited to share this epic event of award-winning artists with our global community. 


You will see performances and appearances by: The Avett Brothers, Jason Mraz, Dr. Sanjay Gupta, Ruthie Foster, Michael Franti, Molly Tuttle, Glen Phillips, Graham Nash, Wesley Schultz of the Lumineers, Sarah Jarosz, Jeffrey Gaines, MC Flow, The War and Treaty, Nora Brown, Johnnyswim, Chris Trapper, and Johnny Helm. 



Online streaming is free for everyone. But in order to really get this going, we are speaking out to YOU, our global community.


Why is that?


Well, if you want to see this production come to life, we need your help. 


But first…


A few words about Remarkable Charlotte:


Charlotte Figi shifted the paradigm of wellness and access for all, as the world watched through the expert eyes of Dr. Sanjay Gupta and his truth-seeking docuseries, Weed. Her story of reclaiming a quality of life from pediatric epilepsy with cannabinoid therapy sparked a global effort to showcase the power of cannabis as a natural solution. Her story changed the course of compassionate care for the world. Charlotte’s sudden and tragic passing at the age of thirteen on April 07, 2020, is an urgent reminder that life is precious, that dignity of choice is critical, and that the courage of innocence is a guidepost for human wellness. 



Who is RoC?


RoC is a high-impact nonprofit that is creating a worldwide community where access to plant-based therapies is the cornerstone of helping others. Charlotte’s impact remains the footprint of our path forward, toward care for all through the healing power of the Earth. Her fight paved the foundation for research, education, and impact; our mission carries on her light and legacy through funding research, education, and community services that change lives and open minds. 


How can you help?


In a VARIETY of ways. Not only will your contribution go towards funding this massive production that is gearing up to air, but it also helps RoC to continue our mission of helping millions globally every day. 



Share your brand with millions in the most meaningful and impactful way, celebrating the life of Charlotte. Her life propelled progress for botanical solutions and advocacy for access to them. Your support helps to elevate our mission that began with Charlotte. We have three sponsorship levels available, each incentivized to put your business in the spotlight.   



Consider making a donation and sharing our Kickstarter Campaign. Rewards for backing this campaign include merchandise with our concert logo, designed by Shepard Fairey’s Studio Number One. Kickstarter funds raised (are required) to go to the production costs of the event. 




Not interested in the incentives but love the RoC and want to keep it going? Donate directly to just once or monthly in the amount that you are able to provide. Our one on one support services to clients worldwide are completely free, donations help us to keep it that way. 


Share your smile!

Be a beacon of light just like Charlotte and share your name or your loved one’s name in a quick video saying “Hi my name is ____ from _____ and I rock the RoC for _______!”. Send us your video to and post it to your social media with the hashtag #iROCKtheRoC.


Leave a message 

What are your memories of Charlotte? How has your life been impacted by her light? If you wish to share your feelings and thoughts, head to and leave your personal message there.


April 7th, 2021 at 6pm MT is a date and time you do not want to miss. Celebrate our light, Charlotte Figi and the millions around the globe just like her.